Edward Jones has upgraded CVS Health (NYSE:CVS) to buy from hold, citing a potential turnaround in its Aetna insurance business. The investment firm said it believes CVS (NYSE:CVS) will improve ...

On Thursday, Edward Jones, a financial services firm, upgraded CVS Health (NYSE:CVS) stock from Hold to Buy. The upgrade comes as the stock, which InvestingPro analysis shows is currently ...

Edward Jones last night upgraded CVS Health (CVS) to Buy from Hold. The company could be an attractive turnaround story” with the potential for new management improving in its health insurance ...

NYSE CVS opened at $56.53 on Thursday. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. CVS Health has a fifty-two week low of $43.56 and a fifty ...

Retail pharmacy chain CVS Health (CVS) is scheduled to announce its results for the fourth quarter of 2024 before the market opens on ...

According to Edward Jones, “CVS has seen health care delivery costs rise as more seniors get procedures done. There also have been changes in the Medicare Advantage program along with CVS's own ...

CVS Health (NYSE:CVS – Free Report) had its target price increased by Wolfe Research from 67.00 to 70.00 in a report published on Tuesday morning. Wolfe Research currently has an overweight rating on ...

On Thursday, Edward Jones, a financial services firm, upgraded CVS Health (NYSE:CVS) stock from Hold to Buy. The upgrade comes as the stock, which InvestingPro analysis shows is currently undervalued, ...